SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-009915
Filing Date
2019-06-03
Accepted
2019-06-03 06:31:42
Documents
68
Period of Report
2019-06-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k060319_delmarpharma.htm 8-K 31308
2 CONSENT OF ERNST & YOUNG, LLP f8k060319ex23-1_delmarpharma.htm EX-23.1 3550
3 FINANCIAL STATEMENTS OF DELMAR PHARMACEUTICALS, INC f8k060319ex99-1_delmarpharma.htm EX-99.1 1873883
  Complete submission text file 0001213900-19-009915.txt   6011095

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE dmpi-20180630.xml EX-101.INS 925828
5 XBRL SCHEMA FILE dmpi-20180630.xsd EX-101.SCH 67892
6 XBRL CALCULATION FILE dmpi-20180630_cal.xml EX-101.CAL 47110
7 XBRL DEFINITION FILE dmpi-20180630_def.xml EX-101.DEF 269638
8 XBRL LABEL FILE dmpi-20180630_lab.xml EX-101.LAB 440462
9 XBRL PRESENTATION FILE dmpi-20180630_pre.xml EX-101.PRE 350090
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 19872093
SIC: 2834 Pharmaceutical Preparations